The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking proposals for a full-service maintenance agreement for its Bruker MALDI Biotyper Commercial Module instrument system. The contract requires comprehensive coverage for all repairs and annual preventative maintenance services, including prompt troubleshooting, immediate access to certified replacement parts, and updates from the original manufacturer, with a performance period starting January 16, 2025, and extending for five years with four additional one-year options. This maintenance is crucial for the FDA's mission to monitor antimicrobial resistance in foodborne and zoonotic pathogens, ensuring the instrument operates according to manufacturer specifications. Interested vendors must submit their proposals by 11:59 AM EST on January 21, 2025, and can contact James O’Keefe at 301-796-7371 or via email at James.OKeefeIII@fda.hhs.gov for further information.